Primary Biliary Cirrhosis

As per available reports about 38 journals, 56 Conferences, 68 workshops are presently dedicated exclusively to Primary Biliary Cirrhosis and about 145 articles are being published on the current trends in Primary Biliary Cirrhosis. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to proteomics are being carried out. Primary Biliary Cirrhosis is an autoimmune disease of the liver discernible by the sluggish progressive demolition of the small bile ducts of the liver, with the intra lobular ducts affected initial in the disease. Primary biliary cirrhosis is significantly more common in those with gluten sensitive enteropathy than the normal population.

The Journal of Clinical & Cellular Immunology is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Primary Biliary Cirrhosis. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Clinical & Cellular Immunology provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Primary Biliary Cirrhosis and bioinformatics, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences. OMICS Group International is a pioneer and leading scientific event organizer, publishing around 350 Open access journals and conducting over 150 Scientific Meetings all over the globe annually with the support of more than 150 scientific associations, 30,000 editorial board members, and 3.5 million followers to its credit.